There might be a double opportunity for the compan
Post# of 153329
(Total Views: 331)
Posted On: 05/20/2025 7:10:21 AM
Re: chazzledazzle #153282
There might be a double opportunity for the company to publicize both the first patient dosed in the CRC trial and the "Observed Survival" poster describing at least some CRC results from the Basket Trial (6 patients) being displayed in the ESMO conference in Barcelona on July 4th.
As we know, the contents of the poster at the Munchen poster conference could not be revealed till the conference itself, but perhaps the fact that there will be a CRC poster presented should be included in a CRC dosing PR.
I.e., not only are we starting on a pivotal trial, but we've already had good results in a small sample, so Keep your eyes peeled, folks.
As we know, the contents of the poster at the Munchen poster conference could not be revealed till the conference itself, but perhaps the fact that there will be a CRC poster presented should be included in a CRC dosing PR.
I.e., not only are we starting on a pivotal trial, but we've already had good results in a small sample, so Keep your eyes peeled, folks.
(8)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼